GE HealthCare (GEHC): Director received 777 shares
Kevin Lobo, Director at GE HealthCare, reported a grant / award of 777 shares.
- 777
- Shares
- Traded
- Mar 13, 2026
- Filed
- Mar 17, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Feb 4, 2026Company filing · Form 8-K · ResultsReported its results
- Feb 13, 20265% stakeDodge & Cox reported a passive stake (13G) of 6.9%
- Feb 26, 2026Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 1 more item)
- Mar 13, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 13, 2026, the Board of Directors (the “Board”) of GE HealthCare Technologies Inc. (the “Company”) appointed Kevin A. Lobo to serve as a director of the Company, effective immediately.”
What came next
- Mar 23, 2026CongressDisclosed sale of GEHC — reported range $1,001 - $15,000
- Mar 25, 2026CongressDisclosed sale of GEHC — reported range $1,001 - $15,000
- Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Apr 24, 2026FDARecall: GE HealthCare TRADE IN CARESCAPE TELEMETRY SERVER ARK-2250L - NORTH AMERICA, REF #5697603-902, Product Code KSA; used in conjunction wtih ApexPro CARESCAPE Tel…
- Apr 24, 2026FDARecall: GE HealthCare ApexPro v6.0 eDelivery Software, REF #5700026, Product Code SUV; used in conjunction wtih ApexPro CARESCAPE Telemetry Server (CTS) v6.0; Monitor,…
- Apr 24, 2026FDARecall: GE HealthCare CARESCAPE TELEMETRY SERVER ARK-2250L - NORTH AMERICA, REF #5697603, Product Code KSA; used in conjunction wtih ApexPro CARESCAPE Telemetry Server…
- Apr 24, 2026FDARecall: CASE v7.0 Cardiac Testing System Model no. 3031234-001 Product Code SU3
- Apr 29, 2026Company filing · Form 8-K · ResultsReported its results
- Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.3%
- Apr 30, 2026Insider · 2 peopleInsiders: 2 purchases (~$356K)
- May 1, 2026FDARecall: Giraffe OmniBed Field Replaceable Unit (FRU), Model Numbers 6600-1056-400 and 6600-1461-500
- May 1, 2026FDARecall: Giraffe OmniBed, a combination of an infant incubator and an infant warmer, All Models
- May 1, 2026FDARecall: Giraffe OmniBed Carestations and Giraffe OmniBed Carestation CS1, a combination of an infant incubator and an infant warmer, Model Numbers 2082844-001-XXX
- May 1, 2026Insider · 3 insiders in a week, a first since 2023CFO purchased ~$201K of GEHC shares in the open market
- May 6, 2026Insider · 2 peopleInsiders: 2 purchases (~$5.1M)
- May 8, 2026FDARecall: GE Healthcare AW Server 3.2 ext.6.5; Radiological Image Processing System
- May 8, 2026Insider · 3 insiders in a week, 2nd time since 2023Director purchased ~$63K of GEHC shares in the open market
- May 12, 2026Insider · 4 insiders in a week, a first since 2023Director purchased ~$100K of GEHC shares in the open market
- May 14, 20265% stakeCapital Research Global Investors reported a passive stake (13G) of 4.6%
- May 14, 20265% stakeDodge & Cox reported a passive stake (13G) of 6.9%
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for GE HealthCare
For GE HealthCare, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its GEHC page.
Other recent filings by Kevin Lobo, Director
- SEC Form 4 at GE HealthCare (GEHC)May 26, 2026
- SEC Form 4 at Stryker Corporation (SYK)Nov 8, 2024
- SEC Form 4 at Stryker Corporation (SYK)Nov 8, 2024
- SEC Form 4 at Stryker Corporation (SYK)Nov 8, 2024
The full history of Kevin Lobo, Director is on the profile page.
How this filing works
Explore the data
Common questions
Which GE HealthCare (GEHC) insider traded, and how much?
Kevin Lobo, Director at GE HealthCare, reported a grant / award of 777 shares. Not an open-market trade.
When did it happen, and when was it made public?
Traded: Mar 13, 2026. Filed: Mar 17, 2026. That is 4 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about GE HealthCare recently?
For GE HealthCare, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the GEHC page.
Does this mean GEHC stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at GE HealthCare
- SEC Form 13F-HRNov 16, 2026
- SEC Form 144Nov 4, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its GEHC page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
